特雷哈洛斯增强的冷大气血介导的癌症治疗
Xiaona Cao1, Tianxu Fang2, Mo Chen2
1Department of Biomedical Engineering, McGill University, Montreal, Quebec, Canada; Rosalind & Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada; School of Nursing, Tianjin Medical University, Tianjin, China.
可注射水凝通过增强氧化应激和免疫反应来增强冷大气等离子体 (CAP) 癌症治疗. 这种新的方法改善了瘤细胞的死亡,并抑制了瘤的生长,即使在遥远的部位.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 通过诱导氧化应激,冷大气等离子体 (CAP) 显示出对癌症治疗的前景.
- 提高农业政策的有效性需要新的交付和增强战略.
- 了解CAP对细胞应激通路的影响至关重要.
研究的目的:
- 开发一种可注射的水凝系统,以提高CAP的抗瘤疗效.
- 调查eIF2α酸化在CAP诱导的癌细胞死亡中的作用.
- 通过水凝输送评估CAP与三糖结合的免疫调节作用.
主要方法:
- 使用可注射的水凝用于局部输送CAP和三糖.
- 评估了CAP诱导的氧化应激及其对eIF2α酸化的影响.
- 分析了树突细胞成熟和T细胞治疗后的反应.
- 研究了巨细胞两极分化和瘤微环境调节.
- 评估了与免疫检查点抑制剂 (aPD1) 的组合疗法.
主要成果:
- 通过凝介导的CAP/三糖治疗增强了eIF2α酸化和免疫细胞死亡 (ICD).
- 组合疗法促进了树突细胞成熟和T细胞介导的抗瘤免疫力.
- 与瘤相关的巨细胞转移到类似M1的表型,减少免疫抑制.
- 联合CAP/三糖与aPD1显著抑制了瘤的生长.
- 局部治疗诱导了针对远处瘤的全身抗瘤免疫.
结论:
- 可注射水凝为增强CAP癌症治疗提供了一个可行的平台.
- CAP/三糖治疗调节细胞应激和免疫反应,从而改善抗瘤作用.
- 这种组合疗法有可能通过激活全身免疫来治疗原发性和转移性瘤.
更多相关视频
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
相关概念视频
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
